Teva UK – Further supplementary written evidence, 1 November 2021
| Published: | Wednesday 17 November 2021 @ 17:40 |
|---|---|
| Publication type: | Scrutiny evidence |
| Committee: | Windsor Framework Sub-Committee |
Work packages
-
Impact of the Protocol on the provision of medicines to Northern Ireland
Wednesday 6 October 2021 -
Files
-
Teva UK Limited - Supplementary written evidence 01.11.2021.docx
File size: 26653